A clinical approach to reveal mechanism and treatment of steroid induced diabetes
Not Applicable
- Conditions
- Diabetes
- Registration Number
- JPRN-UMIN000037040
- Lead Sponsor
- Kumamoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are allergic to the target drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method measurement of HbA1c, glucose, IRI, glucagon, GLP-1, HOMA-R before and 3~6 months after the treatment of glucocorticoids.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie glucocorticoid-induced diabetes in clinical settings?
How does JPRN-UMIN000037040 compare to standard-of-care in managing steroid-induced hyperglycemia?
Are there specific biomarkers for predicting glucocorticoid-induced diabetes risk in patients?
What are the potential adverse events associated with glucocorticoid therapy in diabetes patients?
What combination therapies are being explored alongside glucocorticoids for diabetes treatment?